MRK vs UNH: Merck & Co., Inc. vs UnitedHealth Group Incorporated
Side-by-side snapshot of two Healthcare companies — key metrics from our latest data. Reference only, not investment advice.
| Metric | MRK | UNH |
|---|---|---|
| Company | Merck & Co., Inc. | UnitedHealth Group Incorporated |
| Price | $127.50 | $426.09 |
| Market Cap | $314.90B | $386.95B |
| P/E Ratio | 36.02 | 32.06 |
| EPS | $3.54 | $13.29 |
| Dividend Yield | 2.67% | 2.18% |
| 52-Week High | $131.74 | $461.62 |
| 52-Week Low | $76.66 | $234.60 |
| Industry | Drug Manufacturers - General | Healthcare Plans |
| Exchange | NYQ | NYQ |
| Employees | 73,000 | 390,000 |
Merck & Co., Inc. and UnitedHealth Group Incorporated both operate in the Healthcare sector. MRK trades at a market cap of $314.90B against UNH's $386.95B. Valuation-wise, MRK carries a trailing P/E of 36.02 versus 32.06 for UNH. How these figures compare depends on each company's growth profile, margins and outlook — the snapshot above is a starting point for further research, not a recommendation.
Figures are from our latest data snapshot and may not reflect current market prices. See the full profiles: Merck & Co., Inc. and UnitedHealth Group Incorporated. This is not financial advice.
Recommended Reading & Tools
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Philip Fisher's growth-investing classic on evaluating management and moats.
Check Price →Keep budgets, portfolios and goals in one place with a dedicated finance planner.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Data snapshot: 18 July 2026 (Yahoo Finance) · Page last built: